| RS202125502 |
NLRP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS202125581 |
CEP135
|
Health Risk |
Conflicting classifications of pathogenicity |
Microcephaly 8, primary |
| RS202125585 |
ABCD1
|
Health Risk |
Pathogenic/Likely pathogenic |
Adrenoleukodystrophy, Adrenoleukodystrophy |
| RS202125600 |
DLEC1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS202126269 |
MUSK
|
Health Risk |
Conflicting classifications of pathogenicity |
Fetal akinesia deformation sequence 1, Congenital myasthenic syndrome 9 |
| RS202126574 |
RDH12
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa 53, Retinitis pigmentosa |
| RS202126861 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
6 conditions, Cardiomyopathy |
| RS202127176 |
PIEZO1
|
Health Risk |
Conflicting classifications of pathogenicity |
PIEZO1-related disorder, PIEZO1-related disorder |
| RS202127301 |
CD27
|
Health Risk |
Conflicting classifications of pathogenicity |
Lymphoproliferative syndrome 2, Autoinflammatory syndrome |
| RS202127474 |
MSH6
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Lynch syndrome 1 |
| RS202127751 |
IDH3B
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa, IDH3B-related disorder |
| RS202127939 |
NEDD4L
|
Health Risk |
Conflicting classifications of pathogenicity |
Periventricular nodular heterotopia 7, Inborn genetic diseases |
| RS202128129 |
HGSNAT
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa 73, Mucopolysaccharidosis |
| RS202128350 |
ALOX12B
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive congenital ichthyosis 2, Autosomal recessive congenital ichthyosis 2 |
| RS202128397 |
CRB2
|
Health Risk |
Pathogenic/Likely pathogenic |
Focal segmental glomerulosclerosis 9, Steroid-resistant nephrotic syndrome |
| RS202128855 |
BSND
|
Health Risk |
Conflicting classifications of pathogenicity |
Bartter disease type 4A, Inborn genetic diseases |
| RS202129021 |
NPRL3
|
Health Risk |
Conflicting classifications of pathogenicity |
Epilepsy, familial focal |
| RS202129203 |
WRN
|
Health Risk |
Conflicting classifications of pathogenicity |
Werner syndrome, Ovarian cancer |
| RS202129382 |
ZNF469
|
Health Risk |
Conflicting classifications of pathogenicity |
Ehlers-Danlos syndrome, Cardiovascular phenotype |
| RS202129528 |
IFT140
|
Health Risk |
Conflicting classifications of pathogenicity |
Saldino-Mainzer syndrome, Retinitis pigmentosa 80 |
| RS202129717 |
MYH3
|
Health Risk |
Conflicting classifications of pathogenicity |
Distal arthrogryposis type 2B1, Freeman-Sheldon syndrome |
| RS202130220 |
AP3B2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS202130407 |
LAMA5
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS202130413 |
ARSB
|
Health Risk |
Conflicting classifications of pathogenicity |
Mucopolysaccharidosis type 6, Inborn genetic diseases |
| RS202130526 |
TRPM1
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital stationary night blindness 1C, TRPM1-related disorder |
| RS202130794 |
EYS
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa, Retinal dystrophy |
| RS202131052 |
GALC
|
Health Risk |
Pathogenic |
Galactosylceramide beta-galactosidase deficiency, Inborn genetic diseases |
| RS202131129 |
CACNA1S
|
Health Risk |
Conflicting classifications of pathogenicity |
Malignant hyperthermia, susceptibility to |
| RS202132383 |
MYH9
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant nonsyndromic hearing loss 17, MYH9-related disorder |
| RS202132393 |
FGG
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital afibrinogenemia, Congenital afibrinogenemia |
| RS202132436 |
NBPF15
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS202132558 |
PLEC
|
Health Risk |
Conflicting classifications of pathogenicity |
Epidermolysis bullosa simplex 5C, with pyloric atresia |
| RS202132584 |
COL6A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Bethlem myopathy 1A, Inborn genetic diseases |
| RS202132957 |
SKI
|
Health Risk |
Conflicting classifications of pathogenicity |
Shprintzen-Goldberg syndrome, Shprintzen-Goldberg syndrome |
| RS202133351 |
PSEN2
|
Health Risk |
Conflicting classifications of pathogenicity |
Alzheimer disease 4, Dilated cardiomyopathy 1V |
| RS202133740 |
MYO18B
|
Health Risk |
Conflicting classifications of pathogenicity |
MYO18B-related disorder, Inborn genetic diseases |
| RS202133782 |
NOTCH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Adams-Oliver syndrome 5, Familial thoracic aortic aneurysm and aortic dissection |
| RS202133880 |
LAMA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Ataxia - intellectual disability - oculomotor apraxia - cerebellar cysts syndrome, Ataxia - intellectual disability - oculomotor apraxia - cerebellar cysts syndrome |
| RS202134146 |
COG8
|
Health Risk |
Conflicting classifications of pathogenicity |
COG8-congenital disorder of glycosylation, Inborn genetic diseases |
| RS202134230 |
ARSB
|
Health Risk |
Conflicting classifications of pathogenicity |
Mucopolysaccharidosis type 6, Mucopolysaccharidosis type 6 |
| RS202134424 |
ADA2
|
Health Risk |
Pathogenic |
Deficiency of adenosine deaminase 2, Autoinflammatory syndrome |
| RS202134501 |
LRP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Donnai-Barrow syndrome, Donnai-Barrow syndrome |
| RS202135090 |
LRP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Donnai-Barrow syndrome, Donnai-Barrow syndrome |
| RS202135107 |
LAMB2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, LAMB2-related disorder |
| RS202135204 |
ACTN2
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary familial hypertrophic cardiomyopathy, Dilated cardiomyopathy 1AA |
| RS202135215 |
PLEC
|
Health Risk |
Conflicting classifications of pathogenicity |
Epidermolysis bullosa simplex with nail dystrophy, Epidermolysis bullosa simplex |
| RS202135641 |
SP110
|
Health Risk |
Conflicting classifications of pathogenicity |
Hepatic veno-occlusive disease-immunodeficiency syndrome, Hepatic veno-occlusive disease-immunodeficiency syndrome |
| RS202135871 |
GALC
|
Health Risk |
Pathogenic/Likely pathogenic |
Galactosylceramide beta-galactosidase deficiency, Galactosylceramide beta-galactosidase deficiency |
| RS202136156 |
PTCH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Gorlin syndrome |
| RS202137113 |
NEB
|
Health Risk |
Conflicting classifications of pathogenicity |
Nemaline myopathy 2, Inborn genetic diseases |
| RS202138002 |
P2RX2
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal dominant nonsyndromic hearing loss 41, Autosomal dominant nonsyndromic hearing loss 41 |
| RS202138276 |
PGK1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary skeletal muscle disorder, Hereditary skeletal muscle disorder |
| RS202138550 |
CTC1
|
Health Risk |
Pathogenic/Likely pathogenic |
Cerebroretinal microangiopathy with calcifications and cysts 1, Dyskeratosis congenita |
| RS202139170 |
SRCAP
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS202139330 |
NEB
|
Health Risk |
Conflicting classifications of pathogenicity |
Progressive proximal muscle weakness, Limb pain |
| RS202139349 |
GRIN2B
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability, autosomal dominant 6 |
| RS202139499 |
MYBPC3
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary familial hypertrophic cardiomyopathy, Hypertrophic cardiomyopathy |
| RS202139668 |
DNAH11
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS202139830 |
PIEZO1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS202139846 |
MYOT
|
Health Risk |
Conflicting classifications of pathogenicity |
Myofibrillar myopathy 3, Myofibrillar myopathy 3 |
| RS202139926 |
C1QTNF5;MFRP
|
Health Risk |
Conflicting classifications of pathogenicity |
Isolated microphthalmia 5, Late-onset retinal degeneration |
| RS202140203 |
NPC1
|
Health Risk |
Pathogenic/Likely pathogenic |
Niemann-Pick disease, type C1 |
| RS202140393 |
GBA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Spastic paraplegia, Hereditary spastic paraplegia |
| RS202140402 |
EIF2AK4
|
Health Risk |
Pathogenic |
Familial pulmonary capillary hemangiomatosis, Familial pulmonary capillary hemangiomatosis |
| RS202140956 |
HMCN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Age related macular degeneration 1, Age related macular degeneration 1 |
| RS202141158 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS202141173 |
MYH7
|
Health Risk |
Likely pathogenic |
Hypertrophic cardiomyopathy, Hypertrophic cardiomyopathy 1 |
| RS202141372 |
CHD7
|
Health Risk |
Conflicting classifications of pathogenicity |
CHARGE syndrome, Hypogonadotropic hypogonadism 5 with or without anosmia |
| RS202141422 |
BMPER
|
Health Risk |
Conflicting classifications of pathogenicity |
Diaphanospondylodysostosis, Inborn genetic diseases |
| RS202141423 |
MYL3
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypertrophic cardiomyopathy 8, Hypertrophic cardiomyopathy |
| RS202141567 |
SCN9A
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuropathy, hereditary sensory and autonomic |
| RS202141656 |
ABCA12
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital ichthyosis of skin, ABCA12-related disorder |
| RS202141819 |
MYH7
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Cardiomyopathy |
| RS202141932 |
OBSL1
|
Health Risk |
Conflicting classifications of pathogenicity |
3M syndrome 2, 3M syndrome 2 |
| RS202142174 |
MYO15A
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive nonsyndromic hearing loss 3, Inborn genetic diseases |
| RS202142344 |
ANKRD11
|
Health Risk |
Conflicting classifications of pathogenicity |
KBG syndrome, Inborn genetic diseases |
| RS202142867 |
ASL
|
Health Risk |
Likely pathogenic |
Argininosuccinate lyase deficiency, Argininosuccinate lyase deficiency |
| RS202143056 |
OBSCN
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS202143169 |
RNF213
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS202143236 |
PFKM
|
Health Risk |
Pathogenic |
Peroxisomal biogenesis disorder 3b, Glycogen storage disease |
| RS202143516 |
SCN10A
|
Health Risk |
Conflicting classifications of pathogenicity |
Brugada syndrome 1, Brugada syndrome |
| RS202143667 |
CHD7
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypogonadotropic hypogonadism 5 with or without anosmia, Childhood onset hearing loss |
| RS202143849 |
COL9A2
|
Health Risk |
Conflicting classifications of pathogenicity |
COL9A2-related disorder, Inborn genetic diseases |
| RS202143851 |
FLNB
|
Health Risk |
Conflicting classifications of pathogenicity |
FLNB-Related Spectrum Disorders, FLNB-related disorder |
| RS202144045 |
CHRNB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital myasthenic syndrome 4C, Congenital myasthenic syndrome 2A |
| RS202144137 |
UBE3B
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Oculocerebrofacial syndrome |
| RS202144329 |
POC5
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS202144744 |
TECTA
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS202144797 |
ACO2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS202144877 |
NOTCH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Adams-Oliver syndrome 5, Familial thoracic aortic aneurysm and aortic dissection |
| RS202144949 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Ataxia-telangiectasia syndrome |
| RS202144980 |
FOXN1
|
Health Risk |
Conflicting classifications of pathogenicity |
T-cell immunodeficiency, congenital alopecia |
| RS202145000 |
PDP1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS202145037 |
ABCA13
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS202145169 |
SFTPC
|
Health Risk |
Conflicting classifications of pathogenicity |
Surfactant metabolism dysfunction, pulmonary |
| RS202145311 |
NRXN1
|
Health Risk |
Pathogenic |
Pitt-Hopkins-like syndrome 2, Pitt-Hopkins-like syndrome 2 |
| RS202145313 |
NEB
|
Health Risk |
Conflicting classifications of pathogenicity |
Nemaline myopathy 2, Inborn genetic diseases |
| RS202145435 |
OSMR
|
Health Risk |
Conflicting classifications of pathogenicity |
Amyloidosis, primary localized cutaneous |
| RS202145480 |
IFT80
|
Health Risk |
Conflicting classifications of pathogenicity |
Jeune thoracic dystrophy, Asphyxiating thoracic dystrophy 2 |
| RS202145628 |
L1CAM
|
Health Risk |
Conflicting classifications of pathogenicity |
Spastic paraplegia, Spastic paraplegia |